Orthopedic Surgery Doctors in Fort Polk, LA Accepting Medicare

3 Orthopedic Surgery doctors found. Showing 1 - 3

Jeffery Alan White, D.O. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1585 3rd St, Fort Polk, LA 71459 Phone: 337-531-3896

Dr. Edward Paul Southern, M.D. Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: Bayne-jones Army Community Hospital, 1585 Third St, Fort Polk, LA 71459 Phone: 337-531-3000

Alfonso Santos Alarcon, M.D. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1585 3rd St, Box 81, Fort Polk, LA 71459 Phone: 337-531-3105

News Archive

New active pharmaceutical ingredient may help against severe forms of testicular cancer

A new active pharmaceutical ingredient may help against severe forms of testicular cancer, which only respond inadequately to other therapies.

Muscle genetics plays crucial role in success of marathon runners, study shows

For a few years, running has been fashionable. But there is a great difference between the physical demands of running a few kilometres and doing a marathon. Now Spanish researchers have concluded that genetics plays an essential role in success when completing this long distance.

High cost of potent hepatitis drug presents challenges across the U.S.

Sovaldi, the hepatitis C treatment drug, is considered a breakthrough for patients with the disease. However, since, it won federal approval in December, lawmakers, insurers and patient advocates have begun an all-out revolt over it's high price point of $1,000 a daily pill or $84,000 over 12 weeks of treatment.

Study indicates that patients with a cervical spinal injury may harbor additional spinal damage not visible on regular x-rays

In fact, more than a third of patients who were thought to have low-risk injuries actually have additional damage that may include significant fractures with the potential to produce serious spinal problems if not detected and treated properly.

SuperGen initiates enrollment in first human trial of SGI-110 in MDS and AML

SuperGen, Inc. today announced that it has enrolled the first patient in its first in human study of SGI-110, a second-generation hypomethylating agent, in patients with intermediate-2 or high-risk myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML).

Read more Medical News

› Verified 7 days ago